Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV Prevention
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV Prevention
Authors
Keywords
-
Journal
Polymers
Volume 14, Issue 6, Pages 1196
Publisher
MDPI AG
Online
2022-03-17
DOI
10.3390/polym14061196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How Can We Support the Use of Oral PrEP Among Young Women who Sell Sex? A PrEP Cascade Analysis
- (2021) B. Hensen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis
- (2019) Haitao Yang et al. Pharmaceutics
- Recent advances in the mucus-interacting approach for vaginal drug delivery: from mucoadhesive to mucus-penetrating nanoparticles
- (2019) Silvia Rossi et al. Expert Opinion on Drug Delivery
- Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review
- (2019) Erin Bradley et al. JOURNAL OF WOMENS HEALTH
- Rational Development of Liposomal Hydrogels: A Strategy for Topical Vaginal Antiretroviral Drug Delivery in the Context of HIV Prevention
- (2019) Maria J. Faria et al. Pharmaceutics
- Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel
- (2019) Jing Li et al. Pharmaceutics
- Ramizol® encapsulation into extended release PLGA micro- and nanoparticle systems for subcutaneous and intramuscular administration: in vitro and in vivo evaluation
- (2018) Leah Wright et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art
- (2018) Gerardo Leyva-Gómez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation
- (2017) Craig S. Schneider et al. Science Advances
- Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system
- (2016) Alexandra Machado et al. Acta Biomaterialia
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphighcells and correlates with HIV-1 viral load
- (2016) Gerard Minuesa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs
- (2016) Cassilda Cunha-Reis et al. JOURNAL OF CONTROLLED RELEASE
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
- (2016) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women
- (2016) Kerry A. Thomson et al. Current Opinion in HIV and AIDS
- Raltegravir Permeability across Blood-Tissue Barriers and the Potential Role of Drug Efflux Transporters
- (2015) M. Tozammel Hoque et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mucus permeating thiomer nanoparticles
- (2015) S. Köllner et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
- (2015) Jeanne M. Marrazzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticle-based drug delivery to the vagina: A review
- (2014) Laura M. Ensign et al. JOURNAL OF CONTROLLED RELEASE
- Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents
- (2013) Yumi Hashiguchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Vaginal Films for Drug Delivery
- (2013) Rita M. Machado et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Vaginal Film Drug Delivery of the Pyrimidinedione IQP-0528 for the Prevention of HIV Infection
- (2012) Anthony S. Ham et al. PHARMACEUTICAL RESEARCH
- Formulation Development of Retrocyclin 1 Analog RC-101 as an Anti-HIV Vaginal Microbicide Product
- (2011) A. B. Sassi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vaginal Microbicide Gel for Delivery of IQP-0528, a Pyrimidinedione Analog with a Dual Mechanism of Action against HIV-1
- (2011) Alamelu Mahalingam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro
- (2011) N. C. L. Zembruski et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acceptability of Vaginal Film, Soft-Gel Capsule, and Tablet as Potential Microbicide Delivery Methods Among African Women
- (2011) Annalene M. Nel et al. JOURNAL OF WOMENS HEALTH
- Contemporary perspectives on vaginal pH and lactobacilli
- (2010) Iara M. Linhares et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Cross-Resistance Profile Determination of Two Second-Generation HIV-1 Integrase Inhibitors Using a Panel of Recombinant Viruses Derived from Raltegravir-Treated Clinical Isolates
- (2010) L. Van Wesenbeeck et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines
- (2010) Kevin J. Whaley et al. ANTIVIRAL RESEARCH
- Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport
- (2010) Jason S. Crater et al. MACROMOLECULAR BIOSCIENCE
- In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
- (2010) Lisa C. Rohan et al. PLoS One
- Vaginal Drug Delivery Systems for HIV Prevention
- (2009) Lisa Cencia Rohan et al. AAPS Journal
- An Evidence-Based Review of Treatment-Related Determinants of Patients' Nonadherence to HIV Medications
- (2009) Mark J. Atkinson et al. AIDS PATIENT CARE AND STDS
- Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
- (2009) S. K. Lai et al. JOURNAL OF VIROLOGY
- Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
- (2009) S. K. Lai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
- (2009) Erik Serrao et al. Retrovirology
- Polystyrene nanoparticle trafficking across alveolar epithelium
- (2008) Nazanin R. Yacobi et al. Nanomedicine-Nanotechnology Biology and Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now